Thermo Fisher opens ultra-cold facility in EU to accelerate advanced therapies development

US-based Thermo Fisher Scientific Inc. has opened a new clinical and commercial ultra-cold facility in the European Unio...

June 3, 2024 | Monday | News
CPHI North America expanding Bioproduction focus for 2025

CPHI North America reports soaring attendance and palpable excitement on the show floor, as investment returns and biolo...

May 9, 2024 | Thursday | News
Merck KGaA Darmstadt Germany announces largest investment in Asia

Merck KGaA Darmstadt Germany has announced its largest investment in Asia through a groundbreaking ceremony of its state...

May 29, 2024 | Wednesday | News
“There’s a growing focus on developing novel ADCs tailored to address unmet medical needs”

Can you provide an overview of Nona Biosciences' integrated antibody discovery services? Nona Biosciences is a global l...

May 31, 2024 | Friday | Opinion
Asahi Kasei completes construction of third assembly plant for Planova virus removal filters in Japan

Asahi Kasei Medical has completed the construction of its third assembly plant for Planova virus removal filters in Nobe...

May 27, 2024 | Monday | News
WuXi AppTec breaks ground on new R&D and manufacturing site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies ...

May 23, 2024 | Thursday | News
West Pharma Services opens new office and warehouse facility in South Korea

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administrati...

May 23, 2024 | Thursday | News
Sartorius partners with Sanofi to commercialise downstream process intensification platform

Germany-based life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop a...

May 13, 2024 | Monday | News
Cell Gene Biobank-based innovation centre to open in South Korea

South Korea-based CHA Bio Group and CIC, a Cambridge, US-based global leader in building and operating innovation commun...

May 13, 2024 | Monday | News
Victorian govt supports IDT to build Australia’s first commercial antibody drug conjugate manufacturing facility

IDT Australia has been awarded a Victoria State Government grant to part fund the establishment of Australia&rsq...

May 7, 2024 | Tuesday | News
Fujifilm to invest additional $1.2 B to expand large-scale cell culture CDMO biz in US

Japan-headquartered Fujifilm Corporation has announced an investment of $1.2 billion in its large-scale cell culture con...

April 15, 2024 | Monday | News
Celltrion picks Wood to expand Songdo biopharma manufacturing hub in South Korea

Wood, a global leader in consulting and engineering, has been selected by leading biopharmaceutical firm Celltrion to ...

April 8, 2024 | Monday | News
Merck expands M Lab collaboration center in Shanghai with additional €14 M investment

Merck, a leading science and technology company, has expanded its M Lab Collaboration Center in Shanghai, the compa...

April 8, 2024 | Monday | News
Merck invests € 300+ M in new life science production site in Korea

Merck invests more than €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. The new si...

March 21, 2024 | Thursday | News
WuXi Biologics to establish new CRDMO facility in Singapore

China's WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has brok...

March 19, 2024 | Tuesday | News
Polyplus expands GMP offer with protein production and adds GMP capacity in Belgium

Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) c...

March 6, 2024 | Wednesday | News
Japan's NEC forges clinical development of Neoantigen Cancer Vaccine

Japan's NEC Corporation, AI and digital tech firm along with Transgene, which develops virus-based immunotherapies for c...

March 5, 2024 | Tuesday | News
Merck injects € 20 M into new distribution centre in Brazil

Merck, a leading science and technology company, is opening a new € 20 million distribution centre in Cajamar, S&...

March 4, 2024 | Monday | News
Samsung Biologics & LegoChem Biosciences in Korea team up for ADC development

South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has signed a p...

February 9, 2024 | Friday | News
The Role of CDMOs in Transforming Healthcare Innovations and Treatments

The Critical Bridge Between Innovation and Market CDMOs act as the essential bridge connecting pharmaceutical research ...

February 7, 2024 | Wednesday | News
SGD Pharma Launches Type I Vials with Corning's Velocity® Coating

SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces ...

February 5, 2024 | Monday | News
WuXi XDC and Celltrion sign MoU for integrated services for Antibody-Drug Conjugates

WuXi XDC, China-based contract research, development and manufacturing organisation (CRDMO) focused on antibody drug con...

January 24, 2024 | Wednesday | News
Korea's Lotte Biologics inks deal with US-based NJ Bio for antibody drug conjugates services

South Korean firm Lotte Biologics has recently signed a strategic business agreement with NJ Bio (hereinafter refer...

January 22, 2024 | Monday | News
Fujirebio & Agappe ink business collaboration for CLIA based immunoassay products

Japan-based Fujirebio Holdings and Indian firm Agappe Diagnostics have entered into an agreement of Contract Development...

January 22, 2024 | Monday | News
Taiwan's Bora Pharma acquires US-based Upsher-Smith for $210 M to fuel global expansion

Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of Upsher-Smith L...

January 19, 2024 | Friday | News
China's WuXi Biologics announces research service agreement worth $20 M with BioNTech

China's WuXi Biologics has signed a research service agreement with Germany-based BioNTech SE, a next generation immunot...

January 11, 2024 | Thursday | News
“Pharma companies in South Korea will need to invest in skill development”

How is the contract manufacturing/development sector evolving in Korea? How is West leveraging opportunities in this spa...

January 5, 2024 | Friday | Opinion
AGC invests 50 Billion Yen to expand biopharmaceutical CDMO capability in Japan

AGC Inc, Japan-headquartered manufacturer of glass, chemicals, and high-tech materials, has decided to expand its biopha...

December 26, 2023 | Tuesday | News
Fujifilm invests $200 M into cell therapy development and manufacturing capabilities in US

Japan-headquartered Fujifilm Corporation has announced the investment of $200 million in two subsidiaries to significant...

December 8, 2023 | Friday | News
Aragen to invest $30 M for new bio-manufacturing site in India

Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics...

October 30, 2023 | Monday | News
Korean firm Samsung Biologics to further expand footprint into European market

Samsung Biologics, South Korea-based contract development and manufacturing organisation (CDMO), and Kurma Partners, a E...

October 24, 2023 | Tuesday | News
WuXi XDC and HKSTP promote development of bioconjugate drug industry in Hong Kong

WuXi XDC, a China-based Contract, Research, Development, Manufacturing Organisation (CRDMO) focused on the antibody drug...

October 19, 2023 | Thursday | News
Thermo Fisher expands manufacturing facility in US for complex biologic treatments

Thermo Fisher Scientific has expanded its manufacturing capacity in St. Louis, US to support biologic therapies for dise...

October 6, 2023 | Friday | News
Lotte Biologics to establish three new bio plants in Korea by 2030

Lotte Biologics has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) for the establ...

October 5, 2023 | Thursday | News
WuXi unveils first vaccines CDMO site in China

WuXi Vaccines, a leading contract development and manufacturing organisation (CDMO) focused on vaccine discovery, develo...

September 27, 2023 | Wednesday | News
Chinese startup Canton Biologics completes 300+ M Yuan series C financing

China-based startup Canton Biologics recently completed a Series C financing round exceeding 300 million yuan. This roun...

September 19, 2023 | Tuesday | News
Cytiva expands scientific, digital, and training offering in China

Recognising the long-term needs of the biopharma industry in China and Asia-Pacific, global life sciences leader Cytiva ...

September 18, 2023 | Monday | News
Korea's Samsung Biologics expands oncology agreement with Bristol Myers Squibb

South Korea-based Samsung Biologics has announced a new agreement with Bristol Myers Squibb (BMS) for large-scale manufa...

September 18, 2023 | Monday | News
Europe opens largest manufacturing facility for microbiome ecosystem therapies

MaaT Pharma, a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem Therapies (ME...

September 12, 2023 | Tuesday | News
BIO Asia-Taiwan 2023: Embracing Asian Dynamics around precision health and CDMO

The Taiwan Bio Industry Organization (Taiwan BIO) and the global Biotechnology Innovation Organization (BIO) ignited Tai...

August 31, 2023 | Thursday | Analysis
China's T-Maximum Biotech selects GenScript CRISPR reagents to target high-grade gliomas

US-based GenScript Biotech, and China-based startup T-Maximum Biotech, a biotechnology company pioneering universal...

August 10, 2023 | Thursday | News
Bora Pharmaceuticals unveils new facility in Taiwan for manufacturing ophthalmic products

Bora Pharmaceuticals, a leading contract development and manufacturing organisation (CDMO), has announced the opening of...

August 4, 2023 | Friday | News
WuXi STA launches first high potency sterile injectable manufacturing line at Wuxi City, China

WuXi STA, a global Contract Research, Development, and Manufacturing Organisation (CRDMO), has launched a first high pot...

July 21, 2023 | Friday | News
GenScript doubles manufacturing capacity with new facility in China

US-based GenScript Biotech Corporation has expanded its cGMP manufacturing capacity for single guide or sgRNA ...

July 7, 2023 | Friday | News
“APAC has one of the fastest drug discovery innovation speeds in the world”

How will the new facility benefit Singapore’s thriving pharmaceutical and biomedical ecosystem?  The Singapo...

July 4, 2023 | Tuesday | Opinion
WuXi Biologics partners with Pharmadule Morimatsu for Singapore CRDMO centre

Pharmadule Morimatsu, a subsidiary of Morimatsu International Holdings, and WuXi Biologics have officially entered ...

June 28, 2023 | Wednesday | News
Fujifilm to enhance presence in Asia for biologics and advanced therapies contract services

Fujifilm Corporation will launch a commercial office in Tokyo to provide enhanced sales support and customer servic...

June 12, 2023 | Monday | News
Korea's Samsung Biologics and Pfizer partner for long-term manufacturing of biosimilars portfolio

South Korea-based Samsung Biologics and American pharma firm Pfizer have recently announced a strategic partnership aime...

June 9, 2023 | Friday | News
China's WuXi Biologics to increase manufacturing capacity in Germany

China-headquartered WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRD...

June 2, 2023 | Friday | News
Japan's Meiji Seika Pharma expands CMO business in India

Japan's Meiji Seika Pharma has announced that Adcock Ingram Pharma Private, an affiliated company of Medreich has comple...

May 31, 2023 | Wednesday | News
West Pharmaceutical Services inaugurates advanced manufacturing facility in Singapore

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, h...

May 24, 2023 | Wednesday | News
Thermo Fisher opens new sterile drug facility in Singapore

American supplier of scientific instrumentation, reagents and consumables, and software services, Thermo Fisher Scientif...

May 19, 2023 | Friday | News
GenScript expands peptide and oligonucleotide production facility in China

US-based GenScript Biotech Corporation has expanded its primary manufacturing facility for oligonucleotide and peptide p...

May 19, 2023 | Friday | News
Merck to open new Asia-Pacific Bioprocessing Centre in South Korea

US-based science and technology company, Merck has signed a non-binding Memorandum of Understanding (MoU) with the Minis...

May 4, 2023 | Thursday | News
Cytiva and Pall Life Sciences complete integration to create global biotech leader

US-based firm Cytiva and the life sciences business of Pall Corporation have completed their integration and are now uni...

May 2, 2023 | Tuesday | News
OBiO Technology opens super factory in China to accelerate cell & gene therapy

OBiO Technology (Shanghai) Corp., a leading gene and cell therapy contract development and manufacturing organisation (C...

April 25, 2023 | Tuesday | News
Cytiva brings X-platform bioreactors to simplify single-use upstream bioprocessing operation

American firm Cytiva has announced the launch of X-platform bioreactors to simplify single-use upstream bioprocessing op...

April 19, 2023 | Wednesday | News
Don't Let Clinical Supply Risks Derail Your Success: Join Our Webinar

Title: Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk Date: May 24, 2023 Synopsis ...

April 12, 2023 | Wednesday | News
Taiwan-based HCmed appoints new Chief Scientific Officer

Taiwan's HCmed Innovations Co., a contract development and manufacturing organisation (CDMO), ahas nnounced the appointm...

April 11, 2023 | Tuesday | News
Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in APAC market

Taiwan-based Bora Pharmaceuticals Co. and Celltrion Asia Pacific, a subsidiary of South Korea-based Celltrion Group Inc,...

April 8, 2023 | Saturday | News
Thermo Fisher expands in France to boost capabilities from development to commercial manufacturing

American supplier of scientific instrumentation, reagents and consumables, Thermo Fisher Scientific is adding early deve...

April 8, 2023 | Saturday | News
US CDMOs seek to address capacity challenges and supply chain contingencies

Ahead of a CPHI North America panel discussion – Redesigning the Supply Chain – The Road to I...

April 5, 2023 | Wednesday | News
Bridgewest Group launches new sterile injectable CDMO in Australia

Global private investment firm Bridgewest Group, recognised for developing innovative companies in life sciences, softwa...

April 6, 2023 | Thursday | News
AGC Biologics inks exosome agreement with Jikei University in Japan for Idiopathic Pulmonary Fibrosis project

AGC Biologics, a US-headquartered biopharmaceutical contract development and manufacturing organisation (CDMO), has sign...

April 4, 2023 | Tuesday | News
Takeda Opens its First Platinum Positive Energy Building in Singapore

Takeda has officialy launched its first ‘positive energy’ manufacturing support building at its site in JTC ...

March 30, 2023 | Thursday | Company results
Thermo Fisher opens cell therapy facility at University of California, San Francisco

Thermo Fisher Scientific Inc. and the University of California, San Francisco (UCSF), in the US, will accelerate advance...

March 28, 2023 | Tuesday | News
Korea's Samsung Biologics invests over KRW 1.9 T in new facility

Samsung Biologics, a leading contract development and manufacturing organisation (CDMO) based in South Korea, has announ...

March 17, 2023 | Friday | News
PlasmidFactory announces appointment of Berthold Hackl and Dr Eduard Ayuso to Board of Directors

Leading contract manufacturer and service provider for plasmid and minicircle DNA - PlasmidFactory - has announced the a...

March 14, 2023 | Tuesday | News
Startups in China accelerate development of gene and cell therapy

China-based startups Porton Advanced Solutions and DanausGT Biotechnology have announced a strategic collaboration ...

March 3, 2023 | Friday | News
GenScript expands footprint in Singapore to provide premium gene synthesis service

GenScript Biotech Corporation has announced the expansion of its Singapore facility to provide a premium gene synthesis ...

March 1, 2023 | Wednesday | News
Startups in China accelerate development of innovative cell and gene therapies

China-based startups Porton Advanced Solutions and Yinjia (Shanghai) Biosciences Co. have announced a strategic partners...

February 27, 2023 | Monday | News
Australian firm AcuraBio partners with Cytiva to expand cGMP plasmid DNA CDMO services

AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organisation (CDMO), will provid...

February 10, 2023 | Friday | News
GenScript ProBio completes nearly $220 M Series C Round of financing in China

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...

January 27, 2023 | Friday | News
Korea's Samsung Biologics to continue expansion in capacity, geography and portfolio in 2023

At the 2023 J.P. Morgan Healthcare Conference in January, Samsung Biologics, a fully integrated CDMO offering state...

January 27, 2023 | Friday | News
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO

Lotte Biologics CEO Richard Won-jik Lee has announced a blueprint to leap forward as a global contract development and m...

January 24, 2023 | Tuesday | News
Ajinomoto and Exelixis partner to develop novel antibody-drug conjugates for cancer treatment

Japan-based Ajinomoto has announced a license agreement with US-based firm Exelixis to incorporate AJICAP, Ajinomoto Co....

January 11, 2023 | Wednesday | News
Aurisco collaborates with Cytiva to build first Oligo FlexFactory in China

Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organisation) in China, i...

January 9, 2023 | Monday | News
WuXi Biologics, GSK ink $1.46 B deal for multiple novel bi- & multi-specific T cell engagers

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...

January 5, 2023 | Thursday | News
ASLAN Pharma, Thermo Fisher partner to manufacture atopic dermatitis drug

Singapore-based ASLAN Pharmaceuticals and Thermo Fisher Scientific have announced a partnership to manufacture a high co...

January 5, 2023 | Thursday | News
WuXi STA launches first continuous manufacturing line in China for oral solids

WuXi STA, a subsidiary of WuXi AppTec, has announced that its first drug product Continuous Manufacturing (CM) line for ...

January 4, 2023 | Wednesday | News
GeneQuantum and WuXi XDC to empower innovative bioconjugates development

China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...

December 28, 2022 | Wednesday | News
Flexibility, Time to market and Strategic collaboration- Key trends of pharma manufacturing in 2023

  In one word, how would you describe 2022? I would describe it as volatile, which means it was very difficult to...

December 19, 2022 | Monday | Opinion
Innoforce opens manufacturing plant in China for CDMO services

Innoforce, a global provider of end-to-end contract development and manufacturing services (CDMO), has announced that it...

December 2, 2022 | Friday | News
Thermo Fisher opens new facility in Hangzhou, China

Thermo Fisher Scientific is opening a new facility in Hangzhou, China, as part of its global effort to help compani...

December 9, 2022 | Friday | News
Catalent completes expansion of clinical supply facility in Shanghai, China

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...

December 9, 2022 | Friday | News
Taiwan's Medeologix buys three Silicon Valley medical device CDMO companies

Medeologix, a Taiwan-based medtech CDMO company, has announced its successful acquisition of three premier medical devic...

November 29, 2022 | Tuesday | News
WuXi opens integrated biologics CRDMO centre in Shanghai

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has launched its...

November 22, 2022 | Tuesday | News
WuXi establishes new vaccines CDMO facility in China

WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO), has entered into an agreemen...

November 15, 2022 | Tuesday | News
I Peace partners with the California Institute for Regenerative Medicine

Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...

November 3, 2022 | Thursday | News
Terumo invests ¥15 B to expand CDMO services outside Japan

Terumo Pharmaceutical Solutions (TPS), a leading manufacturer of injection, primary container, and infusion therapy devi...

November 1, 2022 | Tuesday | News
Lotte Biologics signs MoU with Huons Global for biologics manufacturing

South Korea-based startup Lotte Biologics has signed a memorandum of understanding (MoU) with Huons Global for clinical ...

November 1, 2022 | Tuesday | News
WuXi Biologics launches new manufacturing facility in China

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...

October 26, 2022 | Wednesday | News
Samsung Biologics unlocks additional capacity for production at newest Plant 4

Samsung Biologics, South Korea-based contract development and manufacturing organization (CDMO), has announced that its ...

October 12, 2022 | Wednesday | News
Fujifilm to establish first Bio-CDMO site in Japan

Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...

October 10, 2022 | Monday | News
Cytiva strengthens cell line development with CEVEC acquisition

Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...

October 6, 2022 | Thursday | News
Samsung Biologics to launch new platforms for antibody development process

South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...

September 30, 2022 | Friday | News
Biosyngen boosts cell therapy GMP capabilities in Singapore

Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...

September 28, 2022 | Wednesday | News
WuXi STA opens first high potency oral drug product manufacturing facility

WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...

September 28, 2022 | Wednesday | News
Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan

Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...

September 26, 2022 | Monday | News
Hong Kong-based startup Great Bay Bio secures $15M funding

Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...

September 15, 2022 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls